JFL Life Sciences (NSE:JFLLIFE) ROCE % : 12.87% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is JFL Life Sciences ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. JFL Life Sciences's annualized ROCE % for the quarter that ended in Mar. 2024 was 12.87%.

JFL Life Sciences ROCE % Historical Data

The historical data trend for JFL Life Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JFL Life Sciences ROCE % Chart

JFL Life Sciences Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

21.82

17.89

33.31

18.74

12.87

JFL Life Sciences Semi-Annual Data
	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
ROCE %	Get a 7-Day Free Trial			21.82	17.89	33.31	18.74	12.87

JFL Life Sciences ROCE % Calculation

JFL Life Sciences's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	45.431	/	( ( (490.573 - 151.213)	+	(566.417 - 199.812) )	/ 2 )
	=	45.431	/	( (339.36	+	366.605)	/ 2 )
	=	45.431	/	352.9825
	=	12.87 %

JFL Life Sciences's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Mar. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Mar. 2023 )		(Q: Mar. 2024 )
	=	45.431	/	( ( (490.573 - 151.213)	+	(566.417 - 199.812) )	/ 2 )
	=	45.431	/	( ( 339.36	+	366.605 )	/ 2 )
	=	45.431	/	352.9825
	=	12.87 %

(1) Note: The EBIT data used here is one times the annual (Mar. 2024) EBIT data.

JFL Life Sciences (NSE:JFLLIFE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

JFL Life Sciences ROCE % Related Terms

Thank you for viewing the detailed overview of JFL Life Sciences's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

JFL Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JFL Life Sciences Ltd (NSE:JFLLIFE) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015

Website

https://www.jfllifesciences.com

JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.

JFL Life Sciences Headlines

No Headlines